Skip to main content
Top
Published in: European Radiology 8/2019

Open Access 01-08-2019 | Magnetic Resonance

An alternative approach to contrast-enhanced imaging: diffusion-weighted imaging and T1-weighted imaging identifies and quantifies necrosis in Wilms tumour

Authors: Harriet J. Rogers, Martijn V. Verhagen, Susan C. Shelmerdine, Christopher A. Clark, Patrick W. Hales

Published in: European Radiology | Issue 8/2019

Login to get access

Abstract

Objectives

Volume of necrosis in Wilms tumour is informative of chemotherapy response. Contrast-enhanced T1-weighted MRI (T1w) provides a measure of necrosis using gadolinium. This study aimed to develop a non-invasive method of identifying non-enhancing (necrotic) tissue in Wilms tumour.

Methods

In this single centre, retrospective study, post-chemotherapy MRI data from 34 Wilms tumour patients were reviewed (March 2012–March 2017). Cases with multiple b value diffusion-weighted imaging (DWI) and T1w imaging pre- and post-gadolinium were included. Fractional T1 enhancement maps were generated from the gadolinium T1w data. Multiple linear regression determined whether fitted parameters from a mono-exponential model (ADC) and bi-exponential model (IVIM – intravoxel incoherent motion) (D, D*, f) could predict fractional T1 enhancement in Wilms tumours, using normalised pre-gadolinium T1w (T1wnorm) signal as an additional predictor. Measured and predicted fractional enhancement values were compared using the Bland-Altman plot. An optimum threshold for separating necrotic and viable tissue using fractional T1 enhancement was established using ROC.

Results

ADC and D (diffusion coefficient) provided the strongest predictors of fractional T1 enhancement in tumour tissue (p < 0.001). Using the ADC-T1wnorm model (adjusted R2 = 0.4), little bias (mean difference = − 0.093, 95% confidence interval = [− 0.52, 0.34]) was shown between predicted and measured values of fractional enhancement and analysed via the Bland-Altman plot. The optimal threshold for differentiating viable and necrotic tissue was 33% fractional T1 enhancement (based on measured values, AUC = 0.93; sensitivity = 85%; specificity = 90%).

Conclusions

Combining ADC and T1w imaging predicts enhancement in Wilms tumours and reliably identifies and measures necrotic tissue without gadolinium.

Key Points

• Alternative method to identify necrotic tissue in Wilms tumour without using contrast agents but rather using diffusion and T 1 weighted MRI.
• A method is presented to visualise and quantify necrotic tissue in Wilms tumour without contrast.
• The proposed method has the potential to reduce costs and burden to Wilms tumour patients who undergo longitudinal follow-up imaging as contrast agents are not used.
Literature
1.
go back to reference Pastore G, Znaor A, Spreafico F, Graf N, Pritchard-Jones K, Steliarova-Foucher E (2006) Malignant renal tumours incidence and survival in European children (1978–1997): report from the automated childhood cancer information system project. Eur J Cancer 42:2103–2114 Pastore G, Znaor A, Spreafico F, Graf N, Pritchard-Jones K, Steliarova-Foucher E (2006) Malignant renal tumours incidence and survival in European children (1978–1997): report from the automated childhood cancer information system project. Eur J Cancer 42:2103–2114
2.
go back to reference van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K et al (2017) Position paper: rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol. Nat Rev Urol 14:743–752CrossRefPubMed van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K et al (2017) Position paper: rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol. Nat Rev Urol 14:743–752CrossRefPubMed
3.
go back to reference Boccon-Gibod L, Rey A, Sandstedt B et al (2000) Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9. Med Pediatr Oncol 34:183–190CrossRefPubMed Boccon-Gibod L, Rey A, Sandstedt B et al (2000) Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9. Med Pediatr Oncol 34:183–190CrossRefPubMed
4.
go back to reference McDonald RJ, McDonald JS, Kallmes DF et al (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275:772–782CrossRefPubMed McDonald RJ, McDonald JS, Kallmes DF et al (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275:772–782CrossRefPubMed
5.
go back to reference Humphries PD, Sebire NJ, Siegel MJ, Olsen ØE (2007) Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology 245:848–854CrossRefPubMed Humphries PD, Sebire NJ, Siegel MJ, Olsen ØE (2007) Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology 245:848–854CrossRefPubMed
6.
go back to reference McDonald K, Sebire NJ, Anderson J, Olsen OE (2011) Patterns of shift in ADC distributions in abdominal tumours during chemotherapy-feasibility study. Pediatr Radiol 41:99–106CrossRefPubMed McDonald K, Sebire NJ, Anderson J, Olsen OE (2011) Patterns of shift in ADC distributions in abdominal tumours during chemotherapy-feasibility study. Pediatr Radiol 41:99–106CrossRefPubMed
7.
go back to reference Hales PW, Olsen ØE, Sebire NJ, Pritchard-Jones K, Clark CA (2015) A multi-Gaussian model for apparent diffusion coefficient histogram analysis of Wilms’ tumour subtype and response to chemotherapy. NMR Biomed 28:948–957 Hales PW, Olsen ØE, Sebire NJ, Pritchard-Jones K, Clark CA (2015) A multi-Gaussian model for apparent diffusion coefficient histogram analysis of Wilms’ tumour subtype and response to chemotherapy. NMR Biomed 28:948–957
8.
go back to reference LaViolette PS, Mickevicius NJ, Cochran EJ et al (2014) Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma. Neuro Oncol 16:1599–1606CrossRefPubMedPubMedCentral LaViolette PS, Mickevicius NJ, Cochran EJ et al (2014) Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma. Neuro Oncol 16:1599–1606CrossRefPubMedPubMedCentral
9.
go back to reference Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505 Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505
11.
go back to reference Iima M, Le Bihan D (2015) Clinical intravoxel incoherent motion and diffusion MR imaging: past, present, and future. Radiology 278:13–32CrossRef Iima M, Le Bihan D (2015) Clinical intravoxel incoherent motion and diffusion MR imaging: past, present, and future. Radiology 278:13–32CrossRef
14.
go back to reference Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM (2005) End stage renal disease in patients with Wilms tumor: results from the national Wilms tumor study group and the United States renal data system. J Urol 174:1972–1975 Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM (2005) End stage renal disease in patients with Wilms tumor: results from the national Wilms tumor study group and the United States renal data system. J Urol 174:1972–1975
15.
go back to reference Grigoriev Y, Lange J, Peterson SM et al (2012) Treatments and outcomes for end-stage renal disease following Wilms tumor. Pediatr Nephrol 27:1325–1333CrossRefPubMedPubMedCentral Grigoriev Y, Lange J, Peterson SM et al (2012) Treatments and outcomes for end-stage renal disease following Wilms tumor. Pediatr Nephrol 27:1325–1333CrossRefPubMedPubMedCentral
16.
go back to reference Perazella MA (2012) Onco-nephrology: renal toxicities of chemotherapeutic agents. Clin J Am Soc Nephrol 7:1713–1721CrossRefPubMed Perazella MA (2012) Onco-nephrology: renal toxicities of chemotherapeutic agents. Clin J Am Soc Nephrol 7:1713–1721CrossRefPubMed
17.
go back to reference Chandarana H, Lee VS, Hecht E, Taouli B, Sigmund EE (2011) Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience. Invest Radiol 46:285 Chandarana H, Lee VS, Hecht E, Taouli B, Sigmund EE (2011) Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience. Invest Radiol 46:285
18.
go back to reference Zhang JL, Sigmund EE, Chandarana H et al (2010) Variability of renal apparent diffusion coefficients: limitations of the monoexponential model for diffusion quantification. Radiology 254:783–792CrossRefPubMedPubMedCentral Zhang JL, Sigmund EE, Chandarana H et al (2010) Variability of renal apparent diffusion coefficients: limitations of the monoexponential model for diffusion quantification. Radiology 254:783–792CrossRefPubMedPubMedCentral
19.
go back to reference Le Bihan D, Turner R (1992) The capillary network: a link between IVIM and classical perfusion. Magn Reson Med 27:171–178CrossRefPubMed Le Bihan D, Turner R (1992) The capillary network: a link between IVIM and classical perfusion. Magn Reson Med 27:171–178CrossRefPubMed
20.
go back to reference Grech-Sollars M, Hales PW, Miyazaki K et al (2015) Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain. NMR Biomed 28:468–485CrossRefPubMedPubMedCentral Grech-Sollars M, Hales PW, Miyazaki K et al (2015) Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain. NMR Biomed 28:468–485CrossRefPubMedPubMedCentral
Metadata
Title
An alternative approach to contrast-enhanced imaging: diffusion-weighted imaging and T1-weighted imaging identifies and quantifies necrosis in Wilms tumour
Authors
Harriet J. Rogers
Martijn V. Verhagen
Susan C. Shelmerdine
Christopher A. Clark
Patrick W. Hales
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 8/2019
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5907-z

Other articles of this Issue 8/2019

European Radiology 8/2019 Go to the issue